Skip to main content
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1991 Sep;84(9):513–514. doi: 10.1177/014107689108400902

The gold standard in rheumatoid arthritis.

J T Scott
PMCID: PMC1293405  PMID: 1682491

Full text

PDF
513

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bombardier C., Ware J., Russell I. J., Larson M., Chalmers A., Read J. L. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial. Am J Med. 1986 Oct;81(4):565–578. doi: 10.1016/0002-9343(86)90539-5. [DOI] [PubMed] [Google Scholar]
  2. Capell H. A., Marabani M., Madhok R., Torley H., Hunter J. A. Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period. Q J Med. 1990 Apr;75(276):335–344. [PubMed] [Google Scholar]
  3. Englert H. J., Hughes G. R., Walport M. J. Sulphasalazine and regression of rheumatoid nodules. Ann Rheum Dis. 1987 Mar;46(3):244–245. doi: 10.1136/ard.46.3.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FREEDMAN A., STEINBERG V. L. Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year. Ann Rheum Dis. 1960 Sep;19:243–250. doi: 10.1136/ard.19.3.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. HAMILTON E. B., SCOTT J. T. Hydroxychloroquine sulfate ("plaguenil") in treatment of rheumatoid arthritis. Arthritis Rheum. 1962 Oct;5:502–512. doi: 10.1002/art.1780050507. [DOI] [PubMed] [Google Scholar]
  6. Maini R. N. Heberden Oration, 1988. Exploring immune pathways in rheumatoid arthritis. Br J Rheumatol. 1989 Dec;28(6):466–479. doi: 10.1093/rheumatology/28.6.466. [DOI] [PubMed] [Google Scholar]
  7. Morsman C. D., Livesey S. J., Richards I. M., Jessop J. D., Mills P. V. Screening for hydroxychloroquine retinal toxicity: is it necessary? Eye (Lond) 1990;4(Pt 4):572–576. doi: 10.1038/eye.1990.79. [DOI] [PubMed] [Google Scholar]
  8. PAGE F. Treatment of lupus erythematosus with mepacrine. Lancet. 1951 Oct 27;2(6687):755–758. doi: 10.1016/s0140-6736(51)91643-1. [DOI] [PubMed] [Google Scholar]
  9. Palmer A., Taube D., Welsh K., Bewick M., Gjorstrup P., Thick M. Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation. Lancet. 1989 Jan 7;1(8628):10–12. doi: 10.1016/s0140-6736(89)91672-3. [DOI] [PubMed] [Google Scholar]
  10. Rodnan G. P., Benedek T. G. The early history of antirheumatic drugs. Arthritis Rheum. 1970 Mar-Apr;13(2):145–165. doi: 10.1002/art.1780130207. [DOI] [PubMed] [Google Scholar]
  11. Situnayake R. D., Grindulis K. A., McConkey B. Long-term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods. Ann Rheum Dis. 1987 Mar;46(3):177–183. doi: 10.1136/ard.46.3.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Zvaifler N. J. Antimalarial treatment of rheumatoid arthritis. Med Clin North Am. 1968 May;52(3):759–764. [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES